Magnesium and imidazole propionate

Lei Fan1, Danxia Yu1, Xiangzhu Zhu1

  • 1Department of Medicine, Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center, Nashville, TN, USA.

Clinical Nutrition ESPEN
|January 25, 2021
PubMed
Abstract

Insights

Magnesium (Mg) supplementation significantly reduced circulating imidazole propionate (ImP), a metabolite linked to type 2 diabetes. This suggests Mg may help regulate gut microbial metabolites and improve metabolic health.

Area of Science:

  • Metabolomics
  • Microbiome research
  • Nutritional science

Background:

  • Elevated circulating imidazole propionate (ImP), a microbial metabolite, is associated with type 2 diabetes (T2D) and insulin resistance.
  • Low magnesium (Mg) status may promote gut microbial production of ImP.

Purpose of the Study:

  • To investigate the effect of Mg supplementation on circulating ImP levels.
  • To test the hypothesis that Mg status influences ImP production by gut microbiota.

Main Methods:

  • A 2x2 factorial randomized controlled trial (PPCCT) involving 68 participants at high risk for Mg deficiency.
  • Plasma metabolites were measured using untargeted LC-MS metabolomics.
  • Changes in ImP were correlated with changes in serum and urinary Mg.

Main Results:

  • Mg treatment significantly reduced ImP by 39.9% compared to a 6.0% increase in the placebo arm (P=0.02).
  • Changes in ImP showed a significant negative correlation with changes in urinary Mg (r=-0.31, P<0.01).
  • Mg treatment also affected other metabolites, increasing propionic acid and decreasing glutarate.

Conclusions:

  • Mg supplementation effectively reduces circulating ImP levels.
  • Findings support a role for Mg in modulating gut microbial metabolite production.
  • Further research is needed to confirm these effects and explore mechanisms.

Related Concept Videos

Basicity of Heterocyclic Aromatic Amines01:25

Basicity of Heterocyclic Aromatic Amines

Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
6.6K
Aldehydes and Ketones with Amines: Imine Formation Mechanism01:23

Aldehydes and Ketones with Amines: Imine Formation Mechanism

Imine formation involves the addition of carbonyl compounds to a primary amine. It begins with the generation of carbinolamine through a series of steps involving an initial nucleophilic attack and then several proton transfer reactions. The second part includes the elimination of water, as a leaving group, to give the imine.
Imines are formed under mildly acidic conditions. A pH of 4.5 is ideal for the reaction.
If the pH is low or the solution is too acidic, the reaction slows down in the...
7.6K
&sup1;H NMR: Complex Splitting01:13

¹H NMR: Complex Splitting

A proton M that is coupled to a proton X results in doublet signals for M. However, NMR-active nuclei can be simultaneously coupled to more than one nonequivalent nucleus. When M is coupled to a second proton A, such as in styrene oxide, each peak in the doublet is split into another doublet.
Splitting diagrams or splitting tree diagrams are routinely used to depict such complex couplings. While drawing splitting diagrams, the splitting with the larger coupling constant is usually applied...
1.5K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
483